William K. Murray

Rate of Growth in Melanomas

Wendy Liu, John P. Dowling, William K. Murray et al. · Archives of Dermatology · 2006 · 357 citations

Medicine, Dermatology, Oncology +17

Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma

Olga Kondrashova, Monique Topp, Ksenija Nesic et al. · Nature Communications · 2018 · 292 citations · Full text

Medicine, Molecular Genetics, Oncology +17

TOPGEAR: A Randomized, Phase III Trial of Perioperative ECF Chemotherapy with or Without Preoperative Chemoradiation for Resectable Gastric Cancer: Interim Results from an International, Intergroup Trial of the AGITG, TROG, EORTC and CCTG

Trevor Leong, B. Mark Smithers, Karin Haustermans et al. · Annals of Surgical Oncology · 2017 · 243 citations

Medicine, Oncology, Surgery +15

Distinct Clinical and Pathological Features Are Associated with the BRAFT1799A(V600E) Mutation in Primary Melanoma

Wendy Liu, John W. Kelly, Melanie Trivett et al. · Journal of Investigative Dermatology · 2006 · 187 citations · Full text

Medicine, Genetics, Oncology +16

Initial Experience With Gallium-68 DOTA-Octreotate PET/CT and Peptide Receptor Radionuclide Therapy for Pediatric Patients With Refractory Metastatic Neuroblastoma

Grace Kong, Michael S. Hofman, William K. Murray et al. · Journal of Pediatric Hematology/Oncology · 2015 · 138 citations · Full text

Medicine, Nuclear Medicine, Oncology +17